Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR300 > L23 Drug Design 2: Clinical trials > Flashcards

L23 Drug Design 2: Clinical trials Flashcards

1
Q

How many drugs usually make it to the clinical trial?

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many phases are there in the clinical trial

A

4 + post marketing surveillance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why are clinical trials (human trials) so important?

A

Species differences and human variability i.e. differences in pharmacodynamics and pharmacokinetics must be accounted for

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TF: pre-clinical trial is the most expensive part of drug development

A

False, clinical trial is the most expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TF: most drugs get rejected in the clinical trial

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 3 fundamental questions answered during clinical trials

A

Does it work
Is it safe
How does it compare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which entity regulates all clinical trials, drug approvals and post-marketing surveillance

A

Health Canada

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TF: Drug must pass phase 4 before going onto market

A

False, it can be put on the market after passes phase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the goal of phase 1 of clinical trials

A

determine human safety, dosage, and fundamental pharmacokinetics

takes days or weeks
20-80 healthy volunteers take the drug to reveal potential side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TF: Drug development is most often halted at phase 1

A

False, preliminary work weeds out a lot of potential toxic effects so it isn’t very common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the goal of phase 2 of clinical trials

A

expanded state, to see if the drug works or not i.e. effectiveness and side effects. testing drug for pain and toxicity
also used to identify outliers (PM, URM)

takes weeks or months
100-300 patients suffering from the disease/conditions take the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TF: Documented side effects during phase 2 of clinical trials usually go up with time

A

False, they usually go down with time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the goal of phase 3 of clinical trials

A

Catch rare side effects by studying the drug in more people and for longer periods: efficacy, safety (side-effects, adverse reactions)

several years
1000-3000 patient volunteers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is parallel design for

A

to test the drug compared to one already on the market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is crossover experiment for

A

both groups are given market and test drug at different times + washing out to eliminate variability between 2 groups

(also to compare drug to market drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 2 things that are always required for clinical trial designs

A

randomization and double-blind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are two things that can affect clinical trial designs

A

lifestyle and patient compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why is it important to monitor people for a long time

A
  1. some beneficial effects only being to show after a long time
    e.g. simvastatin showed effectiveness 5 years after consistent used patients suffering chronically

statins in general are more effective the longer you take them

  1. Some drugs can have long-term consequences after only using it for a short term.
    e.g. a drug can help prevent relapses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TF: response to medication is much stronger in hidden application compared to open application

A

False, open application illicits a stronger response

open application: medication is administered by a doctor who talks to the patients (patient knows when its being administered and is being cared for)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is behavioural conditioning

A

it is the ‘acquisition’ of a response after being exposed to it once

e.g. giving a pill without the drug after having taken the drug itself results in a response (although its weak) - this response is termed ‘evocation’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TF: placebo response is purely psychological

A

False, this is because the CNS controls physiological responses in the cardiovascular system, immune system, GIT, endocrine system and respiratory system. Thus placebo effect can be felt al throughout the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TF: people who are worried about side effects are more likely to report them when getting a placebo

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are we hoping to achieve when applying pharmacogenomics in drug development

A

we want to be able to genotype people to know their metabolism (pharmacokinetics) ahead of time to know if how they will potentially respond to a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are toxicogenomics

A

seeing who might have toxic reaction due to metabolic by-products based on genomics (e.g. distribution of p450 enzymes)

25
Q

TF: you can get a yearly injection to prevent osteoporosis

A

True (recast, zoledronic acid)

26
Q

what are the 4 things you need to review before applying for a new drug (after phase 3)

A
  1. characterize exposure database (design experiments, randomization and double-blind
  2. identify drug-related adverse effects
  3. estimate risk or rate of adverse effects
  4. identify risk factors for adverse effecs
27
Q

Bringing a drug from lab to clinic takes _ years, _$ in investment with a _% rate of failure

A

14-17 years
4$ billion
95% rate of failure

28
Q

Why have costs for R&D of new drugs started levelling off (after increasing in the recent years)

A
  1. we have better ways of targeting diseases
  2. big increase in development of orphan drugs
29
Q

Why do so many drugs fail?

A

unclear pathogenesis, drug design is currently a guessing game (low efficacy)

this is evident when looking at drug design for AD

30
Q

What must be done in preparation for the drug hitting the market?

A

-name
-manufacturing requirements (drug delivery system, usually pills are favoured)
-economical (cheap)
-stable drug (long shelf-time)
-soluble
-quality control

31
Q

What can be done to improve drugs that have short half-lives

A

design slow-release capsule that allows for slow absorption
then you only need to take it once a day

32
Q

What is the goal of phase 4 of clinical trials

A

monitor the drug to detect very rare side effects or beneficial effects, post-marketing phase to study effectiveness in general population and optimize drug (dosage, frequency, administration)

e.g. side effect of aspirin in children detected in phase 4

33
Q

For drugs with rare toxicity, more than _ patients must be exposed to generate a signal

A

100 000 patients

34
Q

How is a drug monitored?

A

physician ask questions, pharmacists can notify government if patient reports something

35
Q

TF: Drugs that do not explicitly say that pregnant women should not take it are safe to take when pregnant

A

FALSE!! drug must be approved for pregnant women

36
Q

Why must we be cautious when administering approved drugs to young and old patients?

A

these groups are excluded from clinical trials (along with pregnant women) so special problems or side effects may arise

37
Q

From which phase is patient compliance information taken from

A

phase 4

38
Q

What kind of warning is used for medication that are valuable and important but associated with serious risk

A

black box warning

indicate that maximum precaution must be taken
most serious medication warning required by FDA

39
Q

What are the 3 classes of trials for special cases

A

class 1: emergency, fast trial e.g. COVID-19 vaccines
class 2: for life threatening diseases
class 3: normal

40
Q

TF: Orphan drugs may get shorter time frame from clinical testing to market

A

True

41
Q

What is an example for orphan drug development

A

treatment for metastatic uveal melanoma, rare cancer of the eye

42
Q

What are some major disease targets

A

oncology, infectious diseases, neurology

43
Q

What are checkpoint inhibitor drugs. Explain using an example

A

drugs used in cancer treatment, receptor on T cell or ligand on cancer cell is inhibited using antibodies - blocking checkpoint

PD-1 is a negative costimulatory receptor expressed on activated T-cells. Binding of PD-L1 and PD-L2 to this receptor inhibits T cell function

> blocking receptor on T-cell so that it can no longer be activated by ligand on cancer cell (cancer cell ligand inhibits T-cell recognition of tumour as an invader)

44
Q

What is Pembrolizumab

A

a checkpoint inhibitor effective for non-small cell lung cancer

45
Q

What is another option for cancer treatment other than checkpoint inhibitors

A

target CTLA-4 receptors on T-cells by which T-cells bind to dendritic cells

46
Q

Which drug is used to treat Chronic lymphocytic leukaemia? How does it work?

A

Ibrutinib, highly potent, oral once a day 24 hour target inhibition

Blocking the BTK enzyme responsible for B cell proliferation by forming a bond with Cys-481 (selective)

Promotes apoptosis in CLL cells and inhibits CLL cell migration (metastasis)

47
Q

TF: Those who already had chemotherapy showed higher success rate wth Ibrutinib

A

False

48
Q

What are the two strategies involving antibodies in cancer therapy?

A
  1. antibody delivers toxic compound to tumour cell (specific to tumour cells)
  2. targeting abnormality in tumour cell to inhibit its growth (MAB, different side effects to chemo but extends quality of life)
49
Q

What is radioligand therapy

A

attach radioactive compound to the antibody to target and destroy cancer cell

50
Q

What can be used to treat migraines? how does it work?

A

CGRP (calcitonin-gene related peptide) blocker (MAB)

CGRP levels are abnormally high in certain types of migraines

51
Q

What is the difference between PCSK9 inhibitors and statins when treating CVD

A

statins block the synthesis of cholesterol while PCSK9 inhibitors block PCSK9 thus decreasing circulating levels of cholesterol

52
Q

TF: Combining statins and PCSK9 inhibitors can help reduce the risk of atherosclerosis

A

True!

53
Q

What is a drug that can help treat heart failure

A

Neprilysin blockers

Nepriysin break down naturietic and other vasoactive peptides that work to lower blood pressure and promote sodium excretion

54
Q

What drug is used to cure Hepatitis C

A

Sofosbuvir (Sovaldi)

blocks RNA replication of the virus

55
Q

What is a new vaccine in 2023 that helps babies survive from a certain respiratory virus

A

Respiratory Syncytial Virus (RSV) vaccine (Beyfortus)

56
Q

TF: Intracellular targets are currently well understood and a main focus for future drug development

A

False! we still need to research and understand intracellular targets

57
Q

What does the future hold for drug development (7)

A

-new routes of drug administration
-intracellular target studies
-CNS BBB drugs
-obesity
-AIDS, cancer, gene therapy, antiviral drugs, proteomics, personalized therapy, prevention of dementia (AD, pathogenesis)

58
Q

TF: Drugs developed for humans are ineffective in other animals

A

False! they may be beneficial for pets

PHAR300 (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions